ANDA Abbreviated New Drug Application
Health Care Term
The ANDA submission process is a critical step in the drug development and approval process for generic drugs. It must establish that the proposed generic drug product meets all the same quality, safety, and efficacy standards as the brand-name product. In addition, the ANDA must show that the drug delivery system, dosage form, and labeling are similar to the brand-name product.
The ANDA process saves time and resources for manufacturers of generic drugs, as they do not need to demonstrate the safety and efficacy of the active ingredient or conduct clinical trials. Instead, they must show that their product is the bioequivalent of the brand-name product.
Once approved, generic drugs are typically less expensive than their brand-name counterparts, making them more accessible and affordable for patients. The availability of generic drugs also increases competition in the market, which helps to lower drug prices even further.
Overall, ANDA plays a crucial role in the healthcare industry by ensuring that patients have access to safe, effective, and affordable medications.
More Glossary Terms Beginning with A
-
Accident Year
Insurance Term Letter: A
-
Accumulation Distribution Line
Technical Indicator Letter: A
-
Acquired Fund Fees and Expenses
Financial Term Letter: A
-
Acquisition
Financial Term Letter: A
-
Acquisition Proposal
Financial Term Letter: A
-
Adenocarcinoma
Health Care Term Letter: A
-
Adenosine
Health Care Term Letter: A
-
Adjusted Average Cardmember Loans
Financial Term Letter: A
-
Admitted Insurer
Insurance Term Letter: A
-
ADR American Depositary Receipt
Financial Term Letter: A
-
ADR Average Daily Rate
Hotel & Leisure Term Letter: A
-
ADS American Depositary Share
Financial Term Letter: A
